Medicines for Malaria Venture (MMV) and Rinda Ubuzima, a leading Rwandan health research organization, today announced the launch of a
Back to Home Medicines for Malaria Venture (MMV) and Rinda Ubuzima, a leading Rwandan health research organization, today announced the launch of a
Africa’s first-ever Phase 1 trial of a long-acting injectable for malaria prevention launches in Rwanda
Business Day about 5 hours 1 mins read
Medicines for Malaria Venture (MMV) and Rinda Ubuzima, a leading Rwandan health research organization, today announced the launch of aThis article was sourced from an external publication.
Share this article